Andrea D.
- Country
- Italy
- Department
- UOS Center of Chronic Complex Dermatoses and Genodermatoses
Research Overview
- Efficacy and Safety of Alpelisib in Pediatric and Adult Patients with PIK3CA-Mutated Lymphatic Malformations: A Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety Evaluation of Diacerein 1% Ointment in Generalized Epidermolysis Bullosa Simplex: A Randomized, Double-Blind, Vehicle-Controlled Study
- Phase 2 Evaluation of RLY-2608 in PIK3CA-Related Overgrowth Spectrum and PIK3CA Mutation-Driven Malformations in Adult and Pediatric Populations
Data & Insights
Has run more than one trial at 12 of 51 partner sites.
Specializations
Dermatological Disorders
The investigator specializes in studying rare genetic skin conditions, with particular focus on Epidermolysis Bullosa Simplex (EBS). Their research encompasses therapeutic approaches for managing severe and intermediate subtypes of this condition, especially in its generalized form.
- Generalized EBS Treatment
- Pediatric Dermatology
- Topical Therapeutics
Their expertise extends to developing and evaluating novel topical treatments for genetic skin disorders affecting both adult and pediatric populations.
Vascular Anomalies
The investigator focuses on the treatment of lymphatic malformations, particularly those associated with genetic mutations. Their research interests include targeted molecular therapies for vascular system disorders.
- PIK3CA-Related Conditions
- Lymphatic System Disorders
- Precision Medicine Approaches
Their work encompasses both adult and pediatric populations, investigating innovative therapeutic solutions for complex vascular anomalies.
Age-Specific Therapeutics
The investigator demonstrates expertise in developing age-appropriate treatments across different patient populations, from infants as young as 6 months to adults. Their research methodology considers age-specific therapeutic requirements and safety considerations.
- Pediatric Medicine
- Adult Medicine
- Age-Adapted Treatments
Their work emphasizes the importance of tailored therapeutic approaches for different age groups in rare disease treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.